SCAsource Article Summary Archives - National Ataxia Foundation

Corriendo con la energía en vacío: Comprendiendo como la fatiga afecta la calidad de vida en las ataxias espinocerebelosas

May 8, 2026

Escrito por Alexandra Putka Editado por la Dra. Pragya Goel Traducido por Daphne Rincon ¿Te sientes cansado(a)? No estás solo(a). La fatiga es un síntoma común de las ataxias espinocerebelosas y afecta la calidad de vida. Las ataxias espinocerebelosas (también reconocidas como SCAs) se caracterizan por diversos síntomas, pero la fatiga no siempre está incluida en esta lista. Clínicamente, la fatiga se define como la dificultad para iniciar Read More…

Bile acid treatment prevents movement and balance symptoms in SCA3 animals

April 17, 2026

Written by Jacen Emerson Edited by Juan Mato Repurposed steroid hormone prevents cell death and motor symptoms in animal models of SCA3 A New Treatment and Biomarker for SCA3? Duarte-Silva and colleagues in Portugal recently investigated a drug called tauroursodeoxycholic acid (TUDCA) in an effort to establish new treatments for Read More…

Moving forward with movement sensors for ataxia

March 27, 2026

Written by Carrie Sheeler, PhD Edited by Celeste Suart, PhD Advances in wearable technology for tracking ataxia severity combine coordination changes across different types of movement. How do you know a new treatment is working? This is the key question that clinicians have to answer when developing and testing new therapies. One on one, a patient Read More…

An imbalance in balance with age? How a subpopulation of nerve cells may help us stay steady

March 20, 2026

Written by Dr. Pragya Goel Edited by Dr. Lauren Moore Research in mice shows that a specific cell population in the cerebellum maintains balance as we age. Falls due to imbalance are common and dangerous in the elderly, but what exact changes in the brain are responsible for this is Read More…

Snapshot: ¿Qué es la Arreflexia?

March 13, 2026

Snapshot escrito por: Lin (Summer) Dong Editado por: Sharan Srinivasan, MD Traducido por: Ismael Araujo Aliag La arreflexia, proveniente de la palabra griega “a”, que significa ausencia, es una condición médica caracterizada por la ausencia o reducción de los reflejos. Los reflejos son respuestas involuntarias provocadas por estímulos sensoriales que son esenciales para mantener el correcto funcionamiento del cuerpo. Cuando este complejo Read More…

24/7 Wearable Sensors: A New Way to Track Ataxia

February 27, 2026

Written by Poojashree Chettiar Edited by Pragya Goel, PhD AI and wearable tech may transform how ataxia is monitored Could everyday devices help track ataxia? Finding treatments for neurological disorders like spinocerebellar ataxias (SCAs) and multiple system atrophy (MSA-C) has been challenging. A major reason is the lack of good Read More…

Spinal Cord Damage Detected Prior to Disease Onset in Several SCAs

February 20, 2026

Written by Jacen Emerson Edited by Hannah Shorrock, PhD Human Imaging data reveals worsening spinal cord damage in several Ataxias that can begin before symptoms start. Why does the spinal cord matter in SCA? Rezende and colleagues recently published the most thorough study of spinal cord damage in Spinocerebellar Ataxias Read More…

“¿De dónde vienes, adónde fuiste?”: Midiendo la progresión de la enfermedad en SCA1, 2, 3 y 6

February 13, 2026

Escrito por Alexandra PutkaEditado por Dr Hannah K ShorrockTraducido por Ismael Araujo-Aliaga Científicos caracterizan la progresión de las enfermedades SCA1, 2, 3 y 6, y descubren que los síntomas cambian más rápido en los primeros 10 años de la enfermedad. El diseño de ensayos clínicos para enfermedades raras como las Read More…

RFC1 Ataxia (CANVAS): Modifiers and predictors of disease onset and severity

January 16, 2026

Written by Tala Ortiz Edited by Hannah Shorrock, PhD Repeat length in RFC1 Ataxia, also known as CANVAS, impacts the age of onset of symptoms, type of symptoms, and progression Are there ways to predict the types of symptoms and how a disease will progress in a complex neurogenetic disorder? Scientists have investigated this Read More…

Unraveling the Role of Mitochondria in SCA6 Progression

January 9, 2026

Written by Yujia Li Edited by Priscila Pereira Sena The discovery of first links between mitochondrial dysfunction and SCA6 progression offers new insights for potential treatments. What drives the progression of Spinocerebellar ataxia type 6 (SCA6)? While the exact mechanisms remain unclear, a study by Leung et al. suggests that Read More…

What is Ataxia?

Español

Educational Resources

Info by Ataxia Type

Info by Ataxia Type

Newly Diagnosed?

NAF Ataxia Research

NAF Funded Research by Year

Participate in Research

Learn About Research

Research Support

Drug Development Resources

Research Collaboration

Other Resources

Find Healthcare

Treatment Development

Support Groups

Connect

NAF Resources

Other Resources

Healthcare Provider Resources

Support NAF